The collaboration combines Hobré’s analytics expertise with Fike’s proven safety solutions.
The FDA’s “no questions” letter means the agency has reviewed Onego Bio’s safety dossier and found no reason to challenge its conclusion that the product is safe for consumption.
The purchase agreement, announced Sept. 22, is subject to customary closing conditions.
The OLESSENCE™ line is designed to meet the rising consumer demand for fresh foods made with natural, label-friendly ingredients.
The Burleson plant will significantly strengthen the company’s supply chain, enabling faster distribution and improved product consistency across its cafés.